López MA

Language: Spanish
References: 15
Page: 38-40
PDF size: 205.15 Kb.

ABSTRACT

REFERENCES

1. Instituto Mexicano del Seguro Social. Gob.mx. Disponible en: https://www.gob.mx/imss

2. GuíaSalud P. Guía de Práctica Clínica para el Manejo de Pacientes con Gota. GuíaSalud. 2020. Disponible en: https://portal.guiasalud.es/gpc/gota/

3. Howren A, Tsao NW, Choi HK, Shojania K, Kydd A, Friesen R et al. eHealth-supported decentralized multi-disciplinary care for gout involving rheumatology, pharmacy, and dietetics: proof-of-concept study. Clin Rheumatol. 2020; 39 (4): 1241-1249.

4. New webinar: a multidisciplinary approach to managing gout. Gout Education. 2024. Disponible en: https://gouteducation.org/new-webinar-a-multidisciplinary-approach-to-managing-gout/

5. Punzi L, Chia M, Cipolletta S, Dolcetti C, Galozzi P, Giovinazzi O et al. The role of architectural design for rheumatic patients' wellbeing: the point of view of Environmental Psychology. Reumatismo. 2020; 72 (1): 60-66.

6. Punzi L, Medea G. Understanding and perceptions of gout: an interdisciplinary assessment among patients, physicians and pharmacists in Italy. Reumatismo. 2020; 72 (1): 31-43.

7. Park EH, O'Donnell T, Fritz J. Dual-energy computed tomography applications in rheumatology. Radiol Clin North Am. 2024; 62 (5): 849-863.

8. Sirotti S, Pascart T, Thiele R, Filippou G. Imaging of crystal-induced arthropathies in 2025. Best Pract Res Clin Rheumatol. 2025: 102063.

9. Chou H, Chin TY, Peh WC. Dual-energy CT in gout - A review of current concepts and applications. J Med Radiat Sci. 2017; 64 (1): 41-51.

10. Natsuko PD, Laura SC, Denise CC, Lucio VR, Carlos AS, Fausto SM et al. Differential gene expression of ABCG2, SLC22A12, IL-1β, and ALPK1 in peripheral blood leukocytes of primary gout patients with hyperuricemia and their comorbidities: a case-control study. Eur J Med Res. 2022; 27 (1): 62.

11. Clavijo-Cornejo D, Hernández-González O, Gutierrez M. The current role of NLRP3 inflammasome polymorphism in gout susceptibility. Int J Rheum Dis. 2021; 24 (10): 1257-1265.

12. Dong Z, Zhou J, Jiang S, Li Y, Zhao D, Yang C et al. Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout. Hereditas. 2020; 157 (1): 2.

13. Hoque KM, Dixon EE, Lewis RM, Allan J, Gamble GD, Phipps-Green AJ et al. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion. Nat Commun. 2020; 11 (1): 2767.

14. Lu X, Chen M, Shen J, Xu Y, Wu H. IL-1β functionally attenuates ABCG2 and PDZK1 expression in HK-2 cells partially through NF-?B activation. Cell Biol Int. 2019; 43 (3): 279-289.

15. Notsu T, Kurata Y, Ninomiya H, Taufiq F, Komatsu K, Miake J et al. Inhibition of the uric acid efflux transporter ABCG2 enhances stimulating effect of soluble uric acid on IL-1β production in murine macrophage-like J774.1 cells. Hypertens Res. 2023; 46 (10): 2368-2377.